new_0222_0423|CYT|0|ps_ratio|price_to_book_value|peg_ratio|price|short_interest|dividend_yield|earning_yield|market_cap|pe_ratio|consensus_recommendation|price_target_num_est|price_target|sales_est_1y|sales_est_0y|eps_est_1y|eps_est_0y|ebitda_est_0y|ebitda_est_1y|revenues|ebitda|net_income|price_next_month|price_second_month
new_0222_0423|CYT|1|Cyteir Therapeutics Inc PS Ratio|Cyteir Therapeutics Inc Price to Book Value|Cyteir Therapeutics Inc PEG Ratio|Cyteir Therapeutics Inc Price (USD)|Cyteir Therapeutics Inc Short Interest|Cyteir Therapeutics Inc Dividend Yield|Cyteir Therapeutics Inc Earnings Yield|Cyteir Therapeutics Inc Market Cap (USD)|Cyteir Therapeutics Inc PE Ratio|Cyteir Therapeutics Inc Consensus Recommendation|Cyteir Therapeutics Inc Price Target Num Estimates|Cyteir Therapeutics Inc Price Target (USD)|Cyteir Therapeutics Inc Revenue Estimates for Next Fiscal Year (USD)|Cyteir Therapeutics Inc Revenue Estimates for Current Fiscal Year (USD)|Cyteir Therapeutics Inc EPS Estimates for Next Fiscal Year (USD)|Cyteir Therapeutics Inc EPS Estimates for Current Fiscal Year (USD)|Cyteir Therapeutics Inc EBITDA Estimates for Current Fiscal Year (USD)|Cyteir Therapeutics Inc EBITDA Estimates for Next Fiscal Year (USD)|Cyteir Therapeutics Inc Revenue (Quarterly) (USD)|Cyteir Therapeutics Inc EBITDA (Quarterly) (USD)|Cyteir Therapeutics Inc Net Income (Quarterly) (USD)||
new_0222_0423|CYT|2|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_price|figure_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_whole_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0423|CYT|4|quarterly|daily|quarterly|daily|monthly|daily|daily|daily|quarterly|monthly|monthly|monthly|quarterly|quarterly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly||
new_0222_0423|CYT|5||1.43827160494||1.44117647059|15.3571428571|1.44117647059|1.44117647059|1.44117647059||17.5|30|30|52.5|42|23.3333333333|19.0909090909|28.8571428571|33.6666666667||91.3333333333|91.3333333333||
new_0222_0423|CYT|6||162||170|14|170|170|170||12|7|7|4|5|9|11|7|6||6|6||
new_0222_0423|CYT|7|daily|daily|daily|market_daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly||
new_0222_0423|CYT|20200315||||||||||||||||||||-5.943|-5.929||
new_0222_0423|CYT|20200615||||||||||||||||||||-4.426|-4.498||
new_0222_0423|CYT|20200915||||||||||||||||||||-4.938|-5.036||
new_0222_0423|CYT|20201215||||||||||||||||||||-5.285|-5.36||
new_0222_0423|CYT|20210315||||||||||||||||||||-7.234|-7.312||
new_0222_0423|CYT|20210615||3.7649||17.4|31739||-5.3646|599.7188||||||||||||-11.197|-11.295|17.32|21.4
new_0222_0423|CYT|20210715||3.3444||19.01|529845||-29.3275|648.3341||1.5|4|31.5|||-1.7509|-1.5946|-20.9089|-22.2327||||19.39|19.25
new_0222_0423|CYT|20210815||3.4289||19.49|1203187||-28.6052|664.7045||1.5|4|31.5|||-1.6509|-2.6|-51.7758|-68.8115||||19.71|19.08
new_0222_0423|CYT|20210915||3.452||18.92|1530426||-29.467|669.1947||||||||||||-11.627|-11.704|19.85|17.55
new_0222_0423|CYT|20211015||3.2862||18.52|2515235||-30.7471|650.1539||||||||||||||18.4|17.91
new_0222_0423|CYT|20211115||3.2046||18.06|2284170||-31.5302|634.0053||1.5|4|31.5|||-1.9391|-2.41|-44.8104|-74.8523||||18.23|16.61
new_0222_0423|CYT|20211215||2.621||14.66|2385290||-38.8428|518.5374||||||||-2.046|-44.1824|||||15.67|11.37
new_0222_0423|CYT|20220115||1.879||10.51|2371387||-54.1804|371.7482||1.5|4|31.5|||-2.1345|-1.8385|-71.225|-91.8378||||9.97|6.08
new_0222_0423|CYT|20220215||1.1263||6.3|||-90.3867|222.8367||1.4|5|24.6|||-2.0258|-1.7708||||||5.28|5.94